Uveal Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
Conditions:   Uveal Melanoma;   Metastatic Interventions:   Drug: 4.7 microCi 225Ac-MTI-201;   Drug: 9.5 microCi of 225Ac-MTI-201;   Drug: 19 microCi of 225Ac-MTI-201;   Drug: 38 microCi of 225Ac-MTI-201;   Drug: 76 microCi of 225Ac-MTI-201;   Drug: 152 microCi of 225Ac-MTI-201;   Drug: 254 microCi of 225Ac-MTI-201;   Dr ug: 424 microCi of 225Ac-MTI-201;   Drug: 564 microCi of 225Ac-MTI-201;   Drug: 750 microCi of 225Ac-MTI-201;   Drug: 998 microCi of 225Ac-MTI-201;   Drug: 1327 microCi of 225Ac-MTI-201 Sponsors:   Modulation Therapeutics, Inc.;   H. Lee Mof...
Source: ClinicalTrials.gov - August 11, 2022 Category: Research Source Type: clinical trials